These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34481495)

  • 1. A self-amplified nanocatalytic system for achieving "1 + 1 + 1 > 3" chemodynamic therapy on triple negative breast cancer.
    Zhou L; Chen J; Sun Y; Chai K; Zhu Z; Wang C; Chen M; Han W; Hu X; Li R; Yao T; Li H; Dong C; Shi S
    J Nanobiotechnology; 2021 Sep; 19(1):261. PubMed ID: 34481495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Specific Expansion of Oxidative Stress by Glutathione Depletion and Use of a Fenton Nanoagent for Enhanced Chemodynamic Therapy.
    Chen Q; Zhou J; Chen Z; Luo Q; Xu J; Song G
    ACS Appl Mater Interfaces; 2019 Aug; 11(34):30551-30565. PubMed ID: 31397998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers.
    Bey EA; Reinicke KE; Srougi MC; Varnes M; Anderson VE; Pink JJ; Li LS; Patel M; Cao L; Moore Z; Rommel A; Boatman M; Lewis C; Euhus DM; Bornmann WG; Buchsbaum DJ; Spitz DR; Gao J; Boothman DA
    Mol Cancer Ther; 2013 Oct; 12(10):2110-20. PubMed ID: 23883585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Magnetic Extracellular Vesicles Mimetics for Enhanced Targeting Chemodynamic Therapy to Overcome Ovary Cancer.
    Wang S; Mao Y; Rong S; Liu G; Cao Y; Yang Z; Yu H; Zhang X; Fang H; Cai Z; Chen Y; Huang H; Li H
    ACS Appl Mater Interfaces; 2024 Jul; 16(30):39021-39034. PubMed ID: 39033517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism.
    Silvers MA; Deja S; Singh N; Egnatchik RA; Sudderth J; Luo X; Beg MS; Burgess SC; DeBerardinis RJ; Boothman DA; Merritt ME
    J Biol Chem; 2017 Nov; 292(44):18203-18216. PubMed ID: 28916726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis.
    Huang X; Dong Y; Bey EA; Kilgore JA; Bair JS; Li LS; Patel M; Parkinson EI; Wang Y; Williams NS; Gao J; Hergenrother PJ; Boothman DA
    Cancer Res; 2012 Jun; 72(12):3038-47. PubMed ID: 22532167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H
    Tian H; Zhang M; Jin G; Jiang Y; Luan Y
    J Colloid Interface Sci; 2021 Apr; 587():358-366. PubMed ID: 33360905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors.
    Huang X; Motea EA; Moore ZR; Yao J; Dong Y; Chakrabarti G; Kilgore JA; Silvers MA; Patidar PL; Cholka A; Fattah F; Cha Y; Anderson GG; Kusko R; Peyton M; Yan J; Xie XJ; Sarode V; Williams NS; Minna JD; Beg M; Gerber DE; Bey EA; Boothman DA
    Cancer Cell; 2016 Dec; 30(6):940-952. PubMed ID: 27960087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone.
    Bey EA; Bentle MS; Reinicke KE; Dong Y; Yang CR; Girard L; Minna JD; Bornmann WG; Gao J; Boothman DA
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11832-7. PubMed ID: 17609380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone.
    Chakrabarti G; Silvers MA; Ilcheva M; Liu Y; Moore ZR; Luo X; Gao J; Anderson G; Liu L; Sarode V; Gerber DE; Burma S; DeBerardinis RJ; Gerson SL; Boothman DA
    Sci Rep; 2015 Nov; 5():17066. PubMed ID: 26602448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.
    Cao L; Li LS; Spruell C; Xiao L; Chakrabarti G; Bey EA; Reinicke KE; Srougi MC; Moore Z; Dong Y; Vo P; Kabbani W; Yang CR; Wang X; Fattah F; Morales JC; Motea EA; Bornmann WG; Yordy JS; Boothman DA
    Antioxid Redox Signal; 2014 Jul; 21(2):237-50. PubMed ID: 24512128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H
    Yan Y; Han R; Zhang H; Song P; Wei X; Hou Y; Yu J; Tang K
    Colloids Surf B Biointerfaces; 2023 Jan; 221():112997. PubMed ID: 36334518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
    Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
    Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-Positive cancer cells by augmentation of oxidative stress-induced DNA damage.
    Su X; Wang J; Jiang L; Chen Y; Lu T; Mendonca MS; Huang X
    Cancer Lett; 2021 Oct; 519():304-314. PubMed ID: 34329742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isopentyl-Deoxynboquinone Induces Mitochondrial Dysfunction and G2/M Phase Cell Cycle Arrest to Selectively Kill
    Jiang L; Liu Y; Tumbath S; Boudreau MW; Chatkewitz LE; Wang J; Su X; Zahid KR; Li K; Chen Y; Yang K; Hergenrother PJ; Huang X
    Antioxid Redox Signal; 2024 Jul; 41(1-3):74-92. PubMed ID: 37950707
    [No Abstract]   [Full Text] [Related]  

  • 16. Harnessing inorganic nanomaterials for chemodynamic cancer therapy.
    Mohammed DF; Madlool HA; Faris M; Shalan BH; Hasan HH; Azeez NF; Abbas FH
    Nanomedicine (Lond); 2022 Oct; 17(24):1891-1906. PubMed ID: 36647807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier-Free H
    Yang T; Zhou M; Gao M; Qin W; Wang Q; Peng H; Yao W; Qiao L; He X
    Small; 2023 Feb; 19(7):e2205692. PubMed ID: 36494182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ROS storm generating nanocomposite for enhanced chemodynamic therapy through H
    Li Y; Wang J; Zhu T; Zhan Y; Tang X; Xi J; Zhu X; Zhang Y; Liu J
    Nanoscale; 2024 May; 16(17):8479-8494. PubMed ID: 38590261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Copper Peroxide Nanodots for H
    Lin LS; Huang T; Song J; Ou XY; Wang Z; Deng H; Tian R; Liu Y; Wang JF; Liu Y; Yu G; Zhou Z; Wang S; Niu G; Yang HH; Chen X
    J Am Chem Soc; 2019 Jun; 141(25):9937-9945. PubMed ID: 31199131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable thermo-sensitive hydrogel loaded hollow copper sulfide nanoparticles for ROS burst in TME and effective tumor treatment.
    Ning S; Mo J; Huang R; Liu B; Fu B; Ding S; Yang H; Cui Y; Yao L
    Front Bioeng Biotechnol; 2023; 11():1191014. PubMed ID: 37200848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.